Saito, J.; Yamatani, A.; Kojima, Y.; Nakakuni, M.; Nakano, K.; Hirose, K.; Nakamura, H.; Hanawa, T.; Akabane, M.
Stability and Dissolution Behavior Changes After Drug Compounding for Pediatric Cardiovascular Pharmacotherapy. Pharmaceutics 2025, 17, 535.
https://doi.org/10.3390/pharmaceutics17040535
AMA Style
Saito J, Yamatani A, Kojima Y, Nakakuni M, Nakano K, Hirose K, Nakamura H, Hanawa T, Akabane M.
Stability and Dissolution Behavior Changes After Drug Compounding for Pediatric Cardiovascular Pharmacotherapy. Pharmaceutics. 2025; 17(4):535.
https://doi.org/10.3390/pharmaceutics17040535
Chicago/Turabian Style
Saito, Jumpei, Akimasa Yamatani, Yuna Kojima, Masayoshi Nakakuni, Kosuke Nakano, Kaoru Hirose, Hidefumi Nakamura, Takehisa Hanawa, and Miki Akabane.
2025. "Stability and Dissolution Behavior Changes After Drug Compounding for Pediatric Cardiovascular Pharmacotherapy" Pharmaceutics 17, no. 4: 535.
https://doi.org/10.3390/pharmaceutics17040535
APA Style
Saito, J., Yamatani, A., Kojima, Y., Nakakuni, M., Nakano, K., Hirose, K., Nakamura, H., Hanawa, T., & Akabane, M.
(2025). Stability and Dissolution Behavior Changes After Drug Compounding for Pediatric Cardiovascular Pharmacotherapy. Pharmaceutics, 17(4), 535.
https://doi.org/10.3390/pharmaceutics17040535